This suggests that studies of PI3K-dependent stemness regulation in the context of cancer progression will benefit from availability of non-transformed cell lines that are nevertheless capable of unlimited self-renewal in the face of oncogenic pathway activation. This evidence concerns the gene PIK3CA and cancer.